Compare LNTH & CUZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | CUZ |
|---|---|---|
| Founded | 1956 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.2B |
| IPO Year | 2015 | N/A |
| Metric | LNTH | CUZ |
|---|---|---|
| Price | $67.59 | $26.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 11 |
| Target Price | ★ $78.00 | $31.09 |
| AVG Volume (30 Days) | 788.1K | ★ 1.5M |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 4.90% |
| EPS Growth | N/A | ★ 3.48 |
| EPS | ★ 2.39 | 0.35 |
| Revenue | ★ $1,525,933,000.00 | $955,949,000.00 |
| Revenue This Year | $0.01 | $15.34 |
| Revenue Next Year | $0.26 | $3.15 |
| P/E Ratio | ★ $28.21 | $75.35 |
| Revenue Growth | 1.95 | ★ 15.46 |
| 52 Week Low | $47.25 | $24.07 |
| 52 Week High | $111.29 | $31.36 |
| Indicator | LNTH | CUZ |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 50.26 |
| Support Level | $63.37 | $26.00 |
| Resistance Level | $67.92 | $26.85 |
| Average True Range (ATR) | 2.06 | 0.64 |
| MACD | -0.37 | -0.03 |
| Stochastic Oscillator | 58.76 | 35.63 |
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
Cousins Properties Inc is a real estate investment trust principally involved in the ownership, management, and development of properties in the Southern United States. Cousins Properties' real estate portfolio mainly comprises offices and mixed-use developments that encompass both apartment and retail space. Offices make up the vast majority of the portfolio in terms of total square footage. The segments operates in following geographical areas: Atlanta, Austin, Charlotte, Dallas, Phoenix, Tampa, and other markets. The company derives nearly all of its revenue in the form of rental income from its properties, the majority of which comes from its office locations. A diverse set of tenants in the cities of Houston and Atlanta represent the company's key markets.